215 related articles for article (PubMed ID: 26808319)
21. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Jin Y; Yang Y
Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinoma.
Fan S; Müller S; Chen ZG; Pan L; Tighiouart M; Shin DM; Khuri FR; Sun SY
Cancer Biol Ther; 2013 Apr; 14(4):365-9. PubMed ID: 23358467
[TBL] [Abstract][Full Text] [Related]
23. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
24. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
[TBL] [Abstract][Full Text] [Related]
25. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.
Wicker CA; Takiar V; Suganya R; Arnold SM; Brill YM; Chen L; Horbinski CM; Napier D; Valentino J; Kudrimoti MR; Yu G; Izumi T
Oral Oncol; 2020 Dec; 111():104949. PubMed ID: 32801084
[TBL] [Abstract][Full Text] [Related]
27. Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma.
Jiang Y; Li Y; Ge H; Wu Y; Zhang Y; Guo S; Zhang P; Cheng J; Wang Y
J Oral Pathol Med; 2021 Nov; 50(10):1040-1049. PubMed ID: 34358365
[TBL] [Abstract][Full Text] [Related]
28. A key genomic signature associated with lymphovascular invasion in head and neck squamous cell carcinoma.
Zhang J; Lin H; Jiang H; Jiang H; Xie T; Wang B; Huang X; Lin J; Xu A; Li R; Zhang J; Yuan Y
BMC Cancer; 2020 Mar; 20(1):266. PubMed ID: 32228488
[TBL] [Abstract][Full Text] [Related]
29. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics-based discovery of PYGM and TNNC2 as potential biomarkers of head and neck squamous cell carcinoma.
Jin Y; Yang Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31324732
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
[TBL] [Abstract][Full Text] [Related]
32. Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
Mohanta S; Sekhar Khora S; Suresh A
Arch Oral Biol; 2019 Mar; 99():92-106. PubMed ID: 30641296
[TBL] [Abstract][Full Text] [Related]
33. Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma.
Li C; Wu ZH; Yuan K
Dis Markers; 2020; 2020():8899337. PubMed ID: 33133307
[TBL] [Abstract][Full Text] [Related]
34. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
35. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
36. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
PeerJ; 2023; 11():e16237. PubMed ID: 37842043
[TBL] [Abstract][Full Text] [Related]
37. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.
Pattje WJ; Melchers LJ; Slagter-Menkema L; Mastik MF; Schrijvers ML; Gibcus JH; Kluin PM; Hoegen-Chouvalova O; van der Laan BF; Roodenburg JL; van der Wal JE; Schuuring E; Langendijk JA
Histopathology; 2013 Aug; 63(2):263-70. PubMed ID: 23763459
[TBL] [Abstract][Full Text] [Related]
38. CAFE MOCHA: An Integrated Platform for Discovering Clinically Relevant Molecular Changes in Cancer-An Example of Distant Metastasis- and Recurrence-Linked Classifiers in Head and Neck Squamous Cell Carcinoma.
Krishnan NM; I M; Hariharan J; Panda B
JCO Clin Cancer Inform; 2018 Dec; 2():1-11. PubMed ID: 30652568
[TBL] [Abstract][Full Text] [Related]
39. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
Schinke H; Shi E; Lin Z; Quadt T; Kranz G; Zhou J; Wang H; Hess J; Heuer S; Belka C; Zitzelsberger H; Schumacher U; Genduso S; Riecken K; Gao Y; Wu Z; Reichel CA; Walz C; Canis M; Unger K; Baumeister P; Pan M; Gires O
Mol Cancer; 2022 Sep; 21(1):178. PubMed ID: 36076232
[TBL] [Abstract][Full Text] [Related]
40. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
